K2 Medical Research at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

K2 Medical Research takes part in 2 sessions at CTAD 2026 in Boston. Its program centres on capacity and recruitment for Alzheimer's trials. Its work reassesses US trial capacity adjusted for population and how blood-based and digital biomarkers are reshaping recruitment.

Organization	CTAD 2026 Attendance
K2 Medical Research Maitland, Florida
k2med.com Clinical trial sites Florida clinical research site network focused on Alzheimer's and memory-loss trials.	Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Population-Adjusted Alzheimer’s Clinical Trial Capacity in the United States: Reassessing the Perception of Site Saturation in High-Burden States (P145) Trial design and endpoints Poster Wed Nov 18 7:15am–5:30pm Blood-Based and Digital Biomarker Strategies Are Reshaping Alzheimer’s Clinical Trial Recruitment, Cohort Readiness, and Site Operations (P256) Trial design and endpoints · Blood and CSF biomarkers

Organization

CTAD 2026 Attendance

K2 Medical Research

Maitland, Florida

k2med.com

Clinical trial sites

Florida clinical research site network focused on Alzheimer's and memory-loss trials.

Poster

Mon Nov 16 – Tue Nov 17
2:00pm Mon – 5:30pm Tue

Population-Adjusted Alzheimer’s Clinical Trial Capacity in the United States: Reassessing the Perception of Site Saturation in High-Burden States (P145)

Trial design and endpoints

Poster

Wed Nov 18
7:15am–5:30pm

Blood-Based and Digital Biomarker Strategies Are Reshaping Alzheimer’s Clinical Trial Recruitment, Cohort Readiness, and Site Operations (P256)

Trial design and endpoints · Blood and CSF biomarkers

Instantly find 20 buyers from K2 Medical Research

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction